Crossmark

Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines

Crossref DOI link: https://doi.org/10.1007/s11481-020-09956-1

Published Online: 2020-09-10

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Maestroni, Georges https://orcid.org/0000-0003-3900-8088
License Information

Text and Data Mining valid from 2020-09-10

Version of Record valid from 2020-09-10
More Information

Article History

Received: 13 August 2020

Accepted: 7 September 2020

First Online: 10 September 2020